ArticleFrontiers in oncology2022

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming.

Sipeng Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.